InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Rosenzweig Richard C, Vice-Président Senior et Conseiller Juridique Général. Insider active across 2 companies, notably Angiodynamics INC. Cumulatively, 19 filings have been recorded. History available since 21 July 2021. The latest transaction was disclosed on 10 October 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Rosenzweig Richard C
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
766.323 shares0Common StockSEC:0000818479-25-000216:0
595.34 shares0Common StockSEC:0000818479-25-000132:0
628.48 shares0Common StockSEC:0001127602-25-012079:0
33,771 shares0Common StockSEC:0001127602-25-008393:0
383.448 shares0Common StockSEC:0001127602-25-001225:0
266.906 shares0Common StockSEC:0001127602-24-025513:0
287.985 shares0Common StockSEC:0001127602-24-020399:0
215.105 shares0Common StockSEC:0001127602-24-012907:0
11,644 shares0Common StockSEC:0001127602-24-008810:0
1,356 shares@ US$33.27100.0% of flowCommon StockSEC:0001127602-24-008232:0
193.809 shares0Common StockSEC:0001127602-24-001317:0
201.097 shares0Common StockSEC:0001127602-23-025917:0
171.053 shares0Common StockSEC:0001127602-23-020837:0
173.656 shares0Common StockSEC:0001127602-23-013150:0
10,003 shares0Common StockSEC:0001127602-23-009260:0
1,137 shares@ US$13.3623.6% of flowCommon StockSEC:0001567619-23-002003:0
3,963 shares0Common StockSEC:0001567619-22-014369:0
1,194 shares@ US$21.3161.8% of flowCommon StockSEC:0001567619-22-002444:0
3,098 shares0Common StockSEC:0001567619-21-013914:0
19 of 19 declarations
About Rosenzweig Richard C
ROSENZWEIG RICHARD C is Senior Vice President and General Counsel. He has 19 filings in total, and in the sampled recent filings, the period runs from 2021-07-23 to 2025-10-15, with the dominant transaction nature listed as Attribution. The companies mentioned are DENTSPLY SIRONA Inc. and Angiodynamics INC.
